G

Gemina Laboratories
GLAB

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
CA$74.97M
EV
CA$76.39M
Shares Outstanding
80.52M
Beta
0.59

Wall Street View

Analyst Rating
NOT_AVAILABLE
Analyst Target Price
-
P/E undefinedE
-
P/Revenue undefinedE
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Gemina Laboratories Ltd.

gainify

G

Gemina Laboratories Ltd.

GLAB

Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company develops LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex ...

Sector

Healthcare

Industry

Biotechnology

CEO

Firth, Brian

Employees

6

IPO Date

2021-08-12

Headquarters

3600 Gilmore Way, Unit 302, Burnaby, British Columbia, V5G 4W8, Canada

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved